Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Andrea Paul

Zentalis Pharmaceuticals, Inc. reported in an 8-K filed August 26, 2025 that Andrea Paul resigned as Chief Legal Officer and Corporate Secretary, effective September 18, 2025. The proxy statement of Zentalis Pharmaceuticals, Inc. reports total compensation of $2,988,669 for Andrea Paul in fiscal 2025, including a base salary of $376,923. Disclosed compensation is on record for 4 fiscal years.

“On August 26, 2025, Andrea Paul informed the Board of Directors of Zentalis Pharmaceuticals, Inc. ("Zentalis" or the "Company") of her intent to resign as Chief Legal Officer and Corporate Secretary of the Company, effective as of September 18, 2025, in order to join the partnership of a large, international law firm.”
Zentalis Pharmaceuticals, Inc. Form 8-K, filed August 26, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Zentalis Pharmaceuticals, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Zentalis Pharmaceuticals, Inc. (ZNTL) $376,923 $2,988,669
2024 Zentalis Pharmaceuticals, Inc. (ZNTL) $502,290 $3,678,975
2023 Zentalis Pharmaceuticals, Inc. (ZNTL) $459,432 $2,629,027
2022 Zentalis Pharmaceuticals, Inc. (ZNTL) $190,385 $6,214,856

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.